| Date Initiated by Firm | February 27, 2014 |
| Date Posted | March 27, 2014 |
| Recall Status1 |
Terminated 3 on September 05, 2014 |
| Recall Number | Z-1300-2014 |
| Recall Event ID |
67567 |
| Product Classification |
Intravascular, subcutaneous implanted catheter - Product Code LJT
|
| Product | PowerPort Slim Implantable Port, indicated for patient therapies requiring repeated access to the vascular system. Product Codes: 1716000, 1716070 |
| Code Information |
Lot Numbers: REXA1302, REXA1350, REXB1160 |
| FEI Number |
3006260740
|
Recalling Firm/ Manufacturer |
Bard Access Systems
605 North 5600 West
Salt Lake City
UT
84116-3738
|
| For Additional Information Contact | Carlos Arriscorreta, Ph.D. 801-522-5706 |
Manufacturer Reason for Recall | Labeling discrepancy.The label states that the implantable port contains silicone suture plugs, however approximately 23% of the units contained in the affected lots have a PowerPort Slim titanium implantable port without silicone suture plugs. |
FDA Determined Cause 2 | Packaging |
| Action | Notified by Urgent Customer Notification Letter date February 13, 2014, customers were asked to immediately examine their inventory and identify any product subject to this notification. In addition, if they have further distributed this product, please identify customers and notify them at once of this notification. Customers may include a copy of this letter in your notification to customers. Customers may choose to use the involved product with the understanding that the kit may contain a PowerPort Slim implantable port without suture plugs, or may return the applicable product for replacement or credit. |
| Quantity in Commerce | 777 |
| Distribution | US Nationwide distribution including WA, KY, IL, and IA. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 �7.55.
|